BOULDER, Colo., March 10, 2026 /PRNewswire/ -- Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today presented at the 2026 MDA Clinical and Scientific ...

Approximately 40% of patients with muscle-invasive bladder cancer achieve a clinical complete response after neoadjuvant ...

Gemcitabine intravesical system+intravenous cetrelimab did not improve bladder-intact event-free survival or OS for pts with MIBC who did not receive radical cystectomy.

Consuming more dietary protein may benefit people with various types of muscular dystrophy, according to a recent study.

NFL free agency is nearly here. We're tracking it all, from the best available players to signings and contract details ...

Plus, tips and testimonials from real women.

Dyne Therapeutics maintains a strong $1.1B cash position, funding operations into mid-2028 despite heavy R&D and operating ...

The most advanced new surgical procedure, AMI, addresses proprioception. This refers to the ability to sense position and movement. In an intact human arm or leg, muscles work in pairs. When a bicep ...

Induction Yervoy (ipilimumab) plus Opdivo (nivolumab) followed by consolidative chemoradiotherapy demonstrated bladder ...

For years, the U.S. government has doubted the stories of those suffering from AHI, commonly called Havana Syndrome. Now, ...